79 related articles for article (PubMed ID: 11482888)
1. Induction of group 17 specific antibodies by pneumococcal type 17F and 17A polysaccharide vaccines.
Frasch CE; Concepcion NF
Biologicals; 2001 Mar; 29(1):11-6. PubMed ID: 11482888
[TBL] [Abstract][Full Text] [Related]
2. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.
de Roux A; Schmöle-Thoma B; Siber GR; Hackell JG; Kuhnke A; Ahlers N; Baker SA; Razmpour A; Emini EA; Fernsten PD; Gruber WC; Lockhart S; Burkhardt O; Welte T; Lode HM
Clin Infect Dis; 2008 Apr; 46(7):1015-23. PubMed ID: 18444818
[TBL] [Abstract][Full Text] [Related]
3. Type-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with Prevenar in children with underlying chronic or recurrent lung diseases.
Navarro D; Escribano A; Cebrián L; Gimeno C; García-Maset L; García-de-Lomas J;
Clin Vaccine Immunol; 2006 Jun; 13(6):665-70. PubMed ID: 16760325
[TBL] [Abstract][Full Text] [Related]
4. Functional antibodies to the O-acetylated pneumococcal serotype 15B capsular polysaccharide have low cross-reactivities with serotype 15C.
Rajam G; Carlone GM; Romero-Steiner S
Clin Vaccine Immunol; 2007 Sep; 14(9):1223-7. PubMed ID: 17609392
[TBL] [Abstract][Full Text] [Related]
5. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
[TBL] [Abstract][Full Text] [Related]
6. Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays.
Skovsted IC; Kerrn MB; Sonne-Hansen J; Sauer LE; Nielsen AK; Konradsen HB; Petersen BO; Nyberg NT; Duus JØ
Vaccine; 2007 Aug; 25(35):6490-500. PubMed ID: 17655983
[TBL] [Abstract][Full Text] [Related]
7. The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.
Bermal N; Szenborn L; Chrobot A; Alberto E; Lommel P; Gatchalian S; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S89-96. PubMed ID: 19325451
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.
Väkeväinen M; Eklund C; Eskola J; Käyhty H
J Infect Dis; 2001 Sep; 184(6):789-93. PubMed ID: 11517443
[TBL] [Abstract][Full Text] [Related]
9. Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults.
Scott DA; Komjathy SF; Hu BT; Baker S; Supan LA; Monahan CA; Gruber W; Siber GR; Lockhart SP
Vaccine; 2007 Aug; 25(33):6164-6. PubMed ID: 17629361
[TBL] [Abstract][Full Text] [Related]
10. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity.
Uddin S; Borrow R; Haeney MR; Moran A; Warrington R; Balmer P; Arkwright PD
Vaccine; 2006 Jul; 24(27-28):5637-44. PubMed ID: 16730399
[TBL] [Abstract][Full Text] [Related]
11. Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.
Ekström N; Väkeväinen M; Verho J; Kilpi T; Käyhty H
Infect Immun; 2007 Apr; 75(4):1794-800. PubMed ID: 17261612
[TBL] [Abstract][Full Text] [Related]
12. A 22-plex chemiluminescent microarray for pneumococcal antibodies.
Pickering JW; Hoopes JD; Groll MC; Romero HK; Wall D; Sant H; Astill ME; Hill HR
Am J Clin Pathol; 2007 Jul; 128(1):23-31. PubMed ID: 17580269
[TBL] [Abstract][Full Text] [Related]
13. Essential criteria for evaluation of pneumococcal conjugate vaccine candidates.
Paradiso P
Vaccine; 2009 Aug; 27 Suppl 3():C15-8. PubMed ID: 19683657
[TBL] [Abstract][Full Text] [Related]
14. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
16. Non-response to specific serotypes likely cause for failure to 23-valent pneumococcal polysaccharide vaccine in the elderly.
Ortqvist A; Henckaerts I; Hedlund J; Poolman J
Vaccine; 2007 Mar; 25(13):2445-50. PubMed ID: 17052816
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
Jackson LA; Neuzil KM; Nahm MH; Whitney CG; Yu O; Nelson JC; Starkovich PT; Dunstan M; Carste B; Shay DK; Baggs J; Carlone GM
Vaccine; 2007 May; 25(20):4029-37. PubMed ID: 17391816
[TBL] [Abstract][Full Text] [Related]
18. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
19. Developing an ELISA using serotype-specific antigens from selected pneumococcal strains of own selection.
Slotved HC; Jacobsen JN; Møller HK; Krogfelt KA
Vaccine; 2007 Mar; 25(13):2513-7. PubMed ID: 17007972
[TBL] [Abstract][Full Text] [Related]
20. Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines.
Brigtsen AK; Kasper DL; Baker CJ; Jennings HJ; Guttormsen HK
J Infect Dis; 2002 May; 185(9):1277-84. PubMed ID: 12001045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]